Orbix Medical Ltd
TECHNOLOGICAL FIELD Medical devices KEY WORDS Minimally invasive Mastopexy, Plastics Surgery, Breast Sagging, Breast Lifting,
Breast Augmentation PROJECT SUMMARY Orbix Medical Ltd (Formerly MIM) develop an innovative technology and a kit that is intended to support and lift soft tissues in different body parts which require lifting and reshaping from aesthetic and other reasons. This, by a minimally invasive approach which simplifies the procedure, reduces recovery period and eliminates scars. In the first stage, Orbix is focusing on developing the breast lifting kit for solving the breast sagging (ptosis) problem. As women age, the breasts may begin to sag or become ptotic. This process is often accelerated by pregnancy and nursing. mastopexy, or breast lifting, may be performed to enhance the shape of the breast and to obtain a more youthful appearance, improved projection, and reduced ptosis. The mastopexy procedure is performed as a standalone procedure or often as part of a breast augmentation procedure. The Mastopexy procedure involves massive interference with both internal and external breast tissues. Unfortunately, the aesthetic improvement achieved comes at the cost of noticeable scars and asymmetry. In addition, the procedure, which is not suitable for the early stage of breast sagging, is an expensive, long term recovery procedure, with potential specific risks and complications and short term effect. The target market for Orbix Mastopexy procedure includes the existing mastopexy market. Since the breast lifting kit reduces risks and presents better aesthetic results, Orbix expects to replace the existing breast mastopexy procedure and also to give a better solution for women afraid of the present mastopexy procedure. Furthermore, Orbix unique procedure and breast lifting kit can be used in conjunction with breast augmentation surgery (which is currently the most popular of all breast surgery procedures) or breast reduction procedures, providing an excellent solution for a large group of women who require breast lift in addition to augmentation (augmentation-pexy), and/or as a preventive measure against ptosis process and enhancing the aesthetic effect. It is also the only solution for early stage of breast sagging and the only corrective measure for women suffering from Pseudo-ptosis, an undesirable, post-surgical process usually observed in postpartum breast atrophy, characterized by inferior pole ptosis with nipple at or above the inframammary fold. ENTREPRENEURS
Mr. Adi Cohen - Executive Chairman, MBA, B.Sc Aeronautics and Space Engineering, B.A. accounting, Meytav technological incubator; Haargaz Group Dr. Eyal Gur - Founder, Clinical internal consultant, M.D., Ph.D., Head of the Microsurgery Department, Sourasky Medical Center Tel-Aviv, Israel. Dr. Moshe Kon - Clinical Advisory Board, M.D., Ph.D., Head of the Department of Plastic, Reconstructive and Handsurgery, UMC Utrecht Mr. Adiel Shefaram - Product developer, a record of success in the development of medical equipment.
TEL: 972-3-5685801 FAX: 972-3-5685881 EMAIL: adi@haargaz.co.il
|
